Since the advent of genetic testing, the diagnostics arena has achieved a momentous leap towards an affordable and accurate evaluation of their health. Even with the pandemic, genetic diagnostics continues to play a vital role today in detecting and alleviating the need for largescale COVID-19 testing. This growing accessibility and acceptance of non-targeted sequencing among patients are responsible for stimulating the market, which is projected to expand from an estimated $10.6 billion from in 2020 to reach $17.3 billion by 2026.
Owing to its ability to evaluate inherited variants and mutations in the DNA sequence associated with fast-growing cancer cells, the genetic diagnostics arena has also become critical in cancer diagnosis and treatment. It is also expected that next-generation sequencing (NGS) will eventually take over as the major technique used in direct-to-consumer genetic testing (DTC-GT) kits. A major factor determining this shift will be the increasing affordability of NGS reagents. With increasing technological adoption, awareness programs, and a decline in costs, the testing kits are likely to witness a significant boost over the coming years.
At this juncture, there are numerous genetic diagnostics solution providers in the arena that furnish the various needs of healthcare organisations. To help them choose the solution provider that best fits their requirements, Healthcare Tech Outlook has compiled a list of some of the prominent genetic diagnostics solution providers. Besides, the magazine also comprises insights from subject matter experts on the industry trends, best practices, recent innovations, and advice for aspiring CIOs and CXOs.
We present to you Healthcare Tech Outlook’s, “Top 10 Genetic Diagnostics Solutions Providers in Europe — 2022.”
